Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options
- PMID: 25699229
- PMCID: PMC4308527
- DOI: 10.5493/wjem.v5.i1.1
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options
Abstract
During the last years increasing evidence implies that human cytomegalovirus (CMV) can be attributed to human malignancies arising from numerous tissues. In this perspective, we will review and discuss the potential mechanisms through which CMV infection may contribute to brain tumors by affecting tumor cell initiation, progression and metastasis formation. Recent evidence also suggests that anti-CMV treatment results in impaired tumor growth of CMV positive xenografts in animal models and potentially increased survival in CMV positive glioblastoma patients. Based on these observations and the high tumor promoting capacity of this virus, the classical and novel antiviral therapies against CMV should be revisited as they may represent a great promise for halting tumor progression and lower cancer deaths.
Keywords: Brain tumor; Cytomegalovirus; Glioblastoma; Medulloblastoma; Oncovirus.
Similar articles
-
Cytomegalovirus and glioblastoma; controversies and opportunities.J Neurooncol. 2015 Jul;123(3):465-71. doi: 10.1007/s11060-015-1734-0. Epub 2015 Feb 15. J Neurooncol. 2015. PMID: 25682092 Review.
-
Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.Med Hypotheses. 2012 May;78(5):657-8. doi: 10.1016/j.mehy.2012.02.003. Epub 2012 Mar 3. Med Hypotheses. 2012. PMID: 22385772
-
Modeling cytomegalovirus infection in mouse tumor models.Front Oncol. 2015 Mar 17;5:61. doi: 10.3389/fonc.2015.00061. eCollection 2015. Front Oncol. 2015. PMID: 25853089 Free PMC article.
-
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.J Neurooncol. 2015 Nov;125(2):307-15. doi: 10.1007/s11060-015-1905-z. Epub 2015 Sep 4. J Neurooncol. 2015. PMID: 26341370 Free PMC article.
-
Cytomegalovirus as an oncomodulatory agent in the progression of glioma.Cancer Lett. 2017 Jan 1;384:79-85. doi: 10.1016/j.canlet.2016.10.022. Epub 2016 Oct 21. Cancer Lett. 2017. PMID: 27777041 Review.
Cited by
-
The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective.Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180304. doi: 10.1098/rstb.2018.0304. Philos Trans R Soc Lond B Biol Sci. 2019. PMID: 30955500 Free PMC article.
-
Vaccination strategies for neuro-oncology.Neuro Oncol. 2015 Nov;17 Suppl 7(Suppl 7):vii15-vii25. doi: 10.1093/neuonc/nov159. Neuro Oncol. 2015. PMID: 26516221 Free PMC article. Review.
-
Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment.Surg Neurol Int. 2019 Oct 11;10:199. doi: 10.25259/SNI_361_2019. eCollection 2019. Surg Neurol Int. 2019. PMID: 31768279 Free PMC article. Review.
-
Cancer cell stemness, responses to experimental genotoxic treatments, cytomegalovirus protein expression and DNA replication stress in pediatric medulloblastomas.Cell Cycle. 2020 Apr;19(7):727-741. doi: 10.1080/15384101.2020.1728025. Epub 2020 Feb 13. Cell Cycle. 2020. PMID: 32054408 Free PMC article.
-
Mutant IDH impairs chromatin binding by PDGFB to promote chromosome instability.bioRxiv [Preprint]. 2025 Feb 25:2025.02.20.639365. doi: 10.1101/2025.02.20.639365. bioRxiv. 2025. PMID: 40060572 Free PMC article. Preprint.
References
-
- Mocarski E, Shenk TR, P . Cytomegaloviruses. In: Knipe D, Howley P, editors. Fields Virology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. pp. 2701–2772.
-
- Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA. 1989;261:3607–3609. - PubMed
-
- Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet. 2005;365:2105–2115. - PubMed
-
- Freeman RB. The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant. 2009;9:2453–2458. - PubMed
-
- Razonable R. Direct and indirect effects of cytomegalovirus: can we prevent them? Enferm Infecc Microbiol Clin. 2010;28:1–5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources